Soy compared to casein meal replacement shakes with energy-restricted diets for obese women: randomized controlled trial

Metabolism: Clinical and Experimental

Volumn 56, Issue 2, 2007, Pages 280-288

  Anderson, James W ^a   Fuller, Jennifer ^a   Patterson, Katy ^a   Blair, Robert ^b   Tabor, Aaron ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Physicians Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CASEIN; GLUCOSE; HOMOCYSTEINE; INSULIN; LIPID; SOYBEAN PROTEIN;

ARTICLE; BEHAVIOR THERAPY; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; ENERGY CONSUMPTION; EVALUATION; FEMALE; FRUIT; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MEAL; OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOYBEAN; UNSPECIFIED SIDE EFFECT; VEGETABLE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CALORIC RESTRICTION; CASEINS; ENDPOINT DETERMINATION; FEMALE; HOMOCYSTINE; HUMANS; INSULIN; LIFE STYLE; LIPIDS; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; PATIENT DROPOUTS; SINGLE-BLIND METHOD; SOY MILK; WAIST-HIP RATIO;

EID: 33846048343     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.10.013     Document Type: Article

References (54)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
2. James P.T., Leach R., Kalamara E., et al. The worldwide obesity epidemic. Obes Res 9 (2001) 228S-233S
3. Stein C.J., and Colditz G.A. The epidemic of obesity. J Clin Endocrinol Metab 89 (2004) 2522-2525
4. Ogden C.L., Flegal K.M., Carroll M.D., et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288 (2002) 1728-1732
5. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
6. Heshka S., Anderson J.W., Atkinson R.L., et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 289 (2003) 1799-1805
7. Anderson J.W., Luan J., and Hoie L.H. Structured weight-loss programs: a meta-analysis of weight loss at 24 weeks and assessment of effects of intensity of intervention. Adv Ther 21 (2004) 61-75
8. Anderson J.W., Konz E.C., Frederich R.C., et al. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 74 (2001) 579-584
9. Tsai A.G., and Wadden T.A. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 142 (2005) 56-66
10. Li X., Maglione M., Tu W., et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 142 (2005) 532-546
11. Heymsfield S.B., van Mierlo C., van der Knaap H.C.M., et al. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes 27 (2003) 537-549
12. Anderson J.W., and Hoie L.H. Weight loss and lipid changes with low-energy diets: comparison of milk-based versus soy-based liquid meal replacement interventions. J Am Coll Nutr 24 (2005) 210-216
13. Flechtner-Mors M., Ditschuneit H.H., Johnson T.D., et al. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res 8 (2000) 399-402
14. Goodman-Gruen D., and Kritz-Silverstein D. Usual dietary isoflavone intake and body composition in postmenopausal women. Menopause 10 (2003) 427-432
15. Yamori Y. Worldwide epidemic of obesity: hope for Japanese diet. Clin Exp Pharmacol Physiol 31 (2004) S2-S4
16. Allison D.B., Gadbury G., Schwartz L.G., et al. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Nutr 57 (2003) 514-522
17. Deibert P., Konig D., Schmidt-Trucksaess A., et al. Weight loss without losing muscle mass in pre-obese and obese subjects induced by high-soy diet. Int J Obes 28 (2004) 1349-1352
18. Kok L., Kreijkamp-Kaspers S., Grobbee D.E., et al. Soy isoflavones, body composition, and physical performance. Maturitas 52 (2006) 102-110
19. Aoyama T., Fukui K., Takamatsu K., et al. Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 16 (2000) 349-354
20. Ishihara K., Oyaizu S., Fukuchi Y., et al. A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice. J Nutr 133 (2003) 752-757
21. Nishi T., Hara H., Asano K., et al. The soybean B-conglycinin B-51-63 fragment suppresses appetite by stimulating cholecystokinin release in rats. J Nutr 133 (2003) 2537-2542
22. Pupovac J., and Anderson G.H. Dietary peptides induce satiety via cholecystokinin-A and peripheral opioid receptors in rats. J Nutr 132 (2002) 2775-2780
23. Naaz A., Yellayi S., Zakroczymski M.A., et al. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144 (2003) 3315-3320
24. Nagasawa A., Fukui K., Kojima M., et al. Divergent effects of soy protein diet on the expression of adipocytokines. Biochem Biophys Res Commun 311 (2003) 909-914
25. Health Management Resources. HMR program for weight management weight loss core curriculum (1999), Health Management Resources, Boston (MA)
26. Tripathy D., Carlsson M., Almgren P., et al. Insulin secretion and sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49 (2000) 975-980
27. Heilbronn L.K., de J.L., Frisard M.I., et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295 (2006) 1539-1548
28. Ginde S.R., Geliebter A., Rubiano F., et al. Air displacement plethysmography: validation in overweight and obese subjects. Obes Res 13 (2005) 1232-1237
29. Akazawa S., Sun F., Ito M., et al. Efficacy of troglitazone on body fat distribution in type 2 diabetes mellitus. Diabetes Care 23 (2000) 1067-1071
30. Shen W., Wang Z., Punyanita M., et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 11 (2003) 5-16
31. Anderson J.W., Greenway F.L., Fujioka K., et al. Bupropion SR significantly enhances weight loss: a 24-week double-blind, placebo-controlled trial with placebo group randomized to bupropion SR during 24-week extension. Obes Res 10 (2002) 633-641
32. Reynolds L.R., Konz E.C., Frederich R.C., et al. Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus. Diabetes Obes Metab 4 (2002) 270-275
33. Anderson J.W., and Konz E.C. Obesity and disease management: effects of weight loss on co-morbid conditions. Obes Res 9 (2001) 326S-334S
34. Gotthelf L, Anderson JW, O'Brien B: Weight loss in overweight or obese individuals with different structured interventions in an intense behavioral program. Obes Res 12:A402004 (Abstract).
35. Wadden T.A., Foster G.D., and Letizia K.A. One-year behavioral treatment of obesity: comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consult Clin Psychol 62 (1994) 165-171
36. Wing R.R., Jeffery R.W., Burton L.R., et al. Food provision vs structured meal plans in the behavioral treatment of obesity. Int J Obes 20 (1996) 56-62
37. Fontaine K.R., Yang D., Gadbury G.L., et al. Results of soy-based meal replacement formula on weight, anthropometry, serum lipids & blood pressure during a 40-week clinical weight loss trial. Nutr J 2 (2003) 14
38. Moeller L.E., Peterson C.T., Hanson K.B., et al. Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women. Menopause 10 (2003) 322-331
39. Wang M.-F., Yamamoto S., Chung H.-M., et al. Antihypocholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J Nutr Sci Vitaminol 41 (1995) 187-195
40. Hori G., Wang M.-F., Chan Y.-C., et al. Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels in hypercholesterolemic adult male volunteers. Biosci Biotechnol Biochem 65 (2001) 72-78
41. Aoyama T., Fukui K., Nakamori T., et al. Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 64 (2000) 2594-2600
42. Nishi T., Hara H., and Tomita F. Soybean B-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats. J Nutr 133 (2003) 352-357
43. Ali A.A., Velasquez M.T., Hansen C.T., et al. Effects of soybean isoflavones, probiotics, and their interaction on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem 15 (2004) 583-590
44. Uesugi T., Toda T., Tsuji K., et al. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 24 (2001) 368-372
45. Zhou J.-R., Pan W., Takebe M., et al. Effects of isoflavone aglycone in the prevention of obesity in a diet-induced obesity mouse model. Atherosclerosis 143 (1999) 81-90
46. Szkudelska T., Nogowski L., Pruszynska-Oszmalek E., et al. Genistein restricts leptin secretion from rat adipocytes. J Steroid Biochem Mol Biol 96 (2005) 301-307
47. Hwang J-T, Park I-J, Shin J-I, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Comm tbd:tbd, 2005.
48. Anderson J.W., Kendall C.W.C., and Jenkins D.J.A. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 22 (2003) 331-339
49. Jayagopal V., Albertazzi P., Kilpatrick E.S., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25 (2002) 1709-1714
50. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76 (2002) 191-1201
51. Moriyama T., Kishimoto K., Nagai K., et al. Soybean β-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of β-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 68 (2004) 352-359
52. Ascencio C., Torres N., Isoard-Acosta F., et al. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 134 (2004) 522-529
53. Iritani N., Sugimoto T., Fukuda H., et al. Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 127 (1997) 1077-1083
54. Dang Z.-C., Audinot V., Papapoulos S.E., et al. Peroxisome proliferator-activated receptor γ (PPAR γ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278 (2003) 962-967